BlackRock Fund Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$60.9M Buy
560,812
+67,142
+14% +$7.29M 0.01% 1551
2016
Q3
$81.3M Buy
493,670
+16,562
+3% +$2.73M 0.02% 1234
2016
Q2
$68.1M Buy
477,108
+9,836
+2% +$1.4M 0.02% 1291
2016
Q1
$60M Buy
467,272
+31,289
+7% +$4.02M 0.01% 1323
2015
Q4
$65.1M Sell
435,983
-52,194
-11% -$7.8M 0.02% 1287
2015
Q3
$81M Buy
488,177
+38,162
+8% +$6.33M 0.02% 1064
2015
Q2
$109M Buy
450,015
+56,691
+14% +$13.7M 0.03% 926
2015
Q1
$111M Buy
393,324
+48,982
+14% +$13.8M 0.03% 907
2014
Q4
$53.7M Buy
344,342
+247,026
+254% +$38.5M 0.01% 1415
2014
Q3
$23M Buy
97,316
+15,346
+19% +$3.63M 0.01% 1866
2014
Q2
$19.4M Sell
81,970
-118,472
-59% -$28M 0.01% 2040
2014
Q1
$66.1M Buy
200,442
+5,860
+3% +$1.93M 0.02% 1193
2013
Q4
$13.3M Sell
194,582
-8,554
-4% -$584K ﹤0.01% 2211
2013
Q3
$14M Buy
203,136
+46,452
+30% +$3.21M ﹤0.01% 2161
2013
Q2
$7.03M Buy
+156,684
New +$7.03M ﹤0.01% 2483